Leading Scientists Discuss the Future of Cannabis Research

Warning message

The subscription service is currently unavailable. Please try again later.

The future of medical cannabis is an altogether complicated and exciting conversation and the outlook includes both plants and pills.

The future of medical cannabis research is an altogether complicated and exciting conversation. Will plants continue to rule the day? Are isolated molecules the best means of treating particular diseases? Do synthetic cannabinoid drugs hold the answer to efficacy and standardization? At this juncture, only one thing is certain: the outlook includes both plants and pills. 

Roger Pertwee, an academic researcher based at the University of Aberdeen in Scotland, believes the future of cannabis will be clinical. As an expert on cannabinoid pharmacology, Pertwee says drugs like Sativex – which was developed in the UK by GW Pharmaceuticals and is comprised notably of a combination of two cannabis-derived cannabinoids – represent the most likely avenue for medical cannabis. 

“This market has a great future as, for example, a lot of potential...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.